1. Which of the following is currently included in the diagnosis of eosinophilic esophagitis (EoE)? a. The presence of chronic or intermittent symptoms related to esophageal dysfunction. b. The need for multiple biopsies taken from the esophageal epithelium. c. Eosinophil-predominant 7. Which of the following is true for endoscopic dilation in EoE patients? a. The procedure has a greater risk of severe side effects, including esophageal perforations, than in other esophageal conditions. b. The efficacy of esophageal dilation in the long term has not been assessed yet. c. One meta-analysis showed that 75% of patients experienced some degree of symptom relief with dilation, at least in the short-term. d. Endoscopic dilation is recommended as the only therapy in EoE patients whose symptoms improve after the procedure.
8. Regarding the potential side effects of therapy in EoE, which of the following is false? a. Esophageal Candida infection is the main short-term side effect of topical corticosteroids in around 10% of treated patients. b. The effect of topical corticosteroids on bone mineral density and the growth rates of treated EoE patients have been demonstrated in long-term follow-up studies. c. Esophageal Candida infection was an asymptomatic finding in follow-up endoscopies in most patients treated with topical corticosteroids. d. An elemental diet has an impact on psychological and social determinants of health-related quality of life in pediatric and adult patients with EoE.
9. Which of the following statements about the long-term management of EoE is not true? a. The well-documented association between the symptoms of EoE and histology findings makes it possible to predict the absence of active eosinophilic inflammation in a patient with no evidence of esophageal symptoms. b. PPIs are efficient in maintaining remission in the long term in most patients 1 year after the dosage is tapered to the minimum effective dose. c. Patients who experienced relapsing inflammation while on low-dose PPIs regained histological remission after dose escalation, suggesting that twice-daily doses are needed in some patients. d. Since EoE is a chronic disease and the patient's needs may evolve over time, the chosen therapeutic option can be also modified in line with the individual patient's characteristics at different time points.
10. Which of the following statements regarding the natural history of EoE is incorrect? a. EoE now represents one of the most common causes of upper gastrointestinal symptoms in children and adults. b. In the absence of treatment, esophageal inflammation and derived symptoms persist from childhood to adulthood. c. In the absence of treatment, EoE significantly reduces patient quality of life. d. Adult patients with EoE usually present nutritional deficiencies as a result of chronic dysphagia.
